Agios Pharmaceuticals AGIO Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's common stock, shares, outstanding?
- Agios Pharmaceuticals (AGIO) reported common stock, shares, outstanding of $59.34M in Q1 2026.
- How has Agios Pharmaceuticals's common stock, shares, outstanding changed year-over-year?
- Agios Pharmaceuticals's common stock, shares, outstanding increased by 2.5% year-over-year, from $57.89M to $59.34M.
- What is the long-term trend for Agios Pharmaceuticals's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's common stock, shares, outstanding has grown at a -3.3% compound annual growth rate (CAGR), from $69.29M to $58.45M.